Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Penderia Technologies is a new medical device company that specializes in creative ways to treat orthopedic ailments.
Linshom is first to deliver an AI enabled, wearable, FDA cleared, operating room quality respiratory profile to the patient bedside.
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Inso Bio is developing automtion tools for genomic sample handling.
Developing blood-based diagnostic tests for the early detection of neurological disorders like Alzheimer's disease.
Autonomous Healthcare is a medical technology company pioneering the use of automation in clinical care workflows
Aldatu Biosciences is the leader in adaptive PCR diagnostics for global health and emerging diseases.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
Sur180 Therapeutics is a female-led business that focuses on novel ways to treating gynecological diseases.
We build applications that use speech to detect subtle changes in brain health.
RocketML is a Super Fast Computational engine for Machine Learning.
GenNext Technologies is a platform that provides instrumentation, software, and services to structural biology researchers.
O2 RegenTech is commercializing cost-effective, easy-to-use wound care solutions.
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Opsin Biotherapeutics develops a pipeline of opsin-based gene therapies for pain management
Venova is creating a unique method of birth control for women that is long-acting, extremely effective, and free of adverse effects.
MaMome uses microbiome analysis and ML to improve maternal health by detecting high-risk pregnancies early.
Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
Advent Therapeutics is focused on providing therapies for micro-orphan applications.
Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.
Gel4Med is the Smart Materials Company paving the way to the future of regenerative medicine.
Opticyte is transforming care for the leading causes of organ failure, including sepsis, with real-time measurements.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
National Institutes of Health has invested in 491 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical Device, Medical, Life Science. The firm invests across 24 different industry categories.
Among tracked funding rounds, SEngine Precision Medicine received $10.0M in a Series A round. National Institutes of Health's total known invested capital is $2.6B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 491 companies.
Recent National Institutes of Health portfolio additions include Penderia Technologies, Linshom Medical, Inc., Eclipse Regenesis, Inso Biosciences, T-NeuroDx. These companies were founded in 2020 or later.